ImmuneSense™ COVID-19 Cross-Reactivity Study

Exclusion Criteria

• •1. Did not develop symptoms related to their diagnosed seasonal coronavirus infection
• •2. Prior diagnosis of COVID-19 or any positive test result for SARS-CoV-2 infection or antibodies test
• •3. Cohabitated with or has had significant exposure (per the Center for Disease Control guidelines) to another individual with known COVID-19
• •4. Protected populations including pregnant women, prisoners, mentally disabled persons, and wards-of-the state.
• •5. Any significant condition, laboratory abnormality, or psychiatric illness that would prevent the participant from safely participating in the study
• •6. Donated more than 500cc or 1 pint of blood in the past 60 days prior to the study blood draw
• •7. Received a COVID-19 vaccine, including a single dose of a multiple dose vaccine regimen
• •8. Participated in a COVID-19/SARS-CoV-2 study or received a SARS-CoV-2 antibody, or other SARS-CoV-2 therapeutic investigational drug or compound that will impact results of the study at the discretion of the investigator, such as but not limited to a SARS-CoV-2 antibody, therapeutic, or other medication that may impact the person's immune response